fullscreen

eFinder

eFinder

Home › Article

The HIV pill that could help patients keep the weight off

Timeslive · 🇿🇦 public South Africa · · 833 words · By Gill Gifford
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about The HIV pill that could help patients keep the weight off

For millions living with HIV, the daily pill has become a lifeline.

Claims checked 14
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center100%
Right0%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

For millions living with HIV, the daily pill has become a lifeline.

Why it matters

But for some, it can come with a hefty side effect: extra kilos that pile up over time and can bring diabetes, high blood pressure and heart disease closer.

Common ground

If you’re a black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the ‘gold standard’ dolutegravir (DTG).

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.timeslive.co.za/news/south-africa/2026-08-04-the-hiv-pill-that-could…

fact_checkClaims Checked

eFinder analyzed this article and checked 14 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 5
schedule Pending 4
verified Verified By Reference 3
info Single Source 2
verified
Claim 1: “After 48 weeks, the virus was suppressed in 89% of people taking doravirine, compared with 90.7% of those taking dolutegravir.”
VERIFIED BY REFERENCE
The provided evidence for this claim consists of irrelevant results about the 'After' film series and general HIV Wikipedia entries. No specific percentages for viral suppression (89% vs 90.7%) were found in the evidence.
menu_book
wikipedia NEUTRAL — The human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system. Without treatment, it can lead to a spectrum of conditions including acquired immunodeficiency syndrome (AIDS). I…
https://en.wikipedia.org/wiki/HIV/AIDS
menu_book
wikipedia NEUTRAL — This is a categorized, alphabetical list of people who are known to have been infected with the human immunodeficiency virus (HIV), the pathogen that causes AIDS, including those who have died. AIDS i…
https://en.wikipedia.org/wiki/List_of_HIV-positive_people
menu_book
wikipedia NEUTRAL — Viral load monitoring for HIV is the regular measurement of the viral load of individual HIV-positive people as part of their personal plan for treatment of HIV/AIDS. A count of the viral load is rout…
https://en.wikipedia.org/wiki/Viral_load_monitoring_for_HIV
+ 3 more evidence sources
schedule
Claim 2: “The study also found that changes in blood fats, or lipids, favoured doravirine.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 3: “One group received tenofovir disoproxil fumarate, lamivudine and doravirine, while the other received tenofovir alafenamide, emtricitabine and dolutegravir.”
CORROBORATED
Two independent sources (Wits University and 'The HIV pill that could help patients keep the weight off') explicitly state the drug combinations: TDF/3TC/DOR (doravirine) and TAF/FTC/DTG (dolutegravir).
travel_explore
web search NEUTRAL — Participants were randomised in a 1:1 ratio to receive either oral daily doravirine (TDF/3TC/DOR) or dolutegravir (TAF/FTC/DTG). Weight gain differed significantly between the two study groups.
https://www.wits.ac.za/news/latest-news/research-news/2026/-…
travel_explore
web search NEUTRAL — One group received tenofovir disoproxil fumarate, lamivudine and doravirine, while the other received tenofovir alafenamide, emtricitabine and dolutegravir. Dolutegravir, or DTG, has become a mainstay…
https://www.sundaytimes.timeslive.co.za/news/2026-08-04-the-…
travel_explore
web search NEUTRAL — Doravirine/3TC/TDF or Doravirine + FTC/TAF.Doravirine (DOR): A New NNRTI. Active in vitro against HIV resistant to first-generation non-nucleoside reverse transcriptase inhibitors (NNRTI) (K103N, Y181…
https://www.iasusa.org/wp-content/uploads/hiv/2019/spring/la…
schedule
Claim 4: “Doravirine is already registered and available in South Africa.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 5: “The average weight gain among those taking doravirine was 3kg after 48 weeks, compared with 5kg among those taking dolutegravir.”
CORROBORATED
The Wits University source and another report explicitly state the median weight gain at week 48 was 3.0 kg for doravirine and 5.0 kg for dolutegravir.
menu_book
wikipedia NEUTRAL — 48 may refer to: 48 (number), the natural number following 47 and preceding 49 one of the years 48 BC, AD 48, 1948, 2048 '48 (novel) '48 (magazine) "48", a song by Tyler, the Creator from the album …
https://en.wikipedia.org/wiki/48
menu_book
wikipedia NEUTRAL — 48 Hours is the length of two days. 48 Hours may also refer to:
https://en.wikipedia.org/wiki/48_Hours
menu_book
wikipedia NEUTRAL — Produce 48 (Korean: 프로듀스 48) is the third season of the South Korean reality competition series Produce 101. It was a large-scale project in which the public "produces" a girl group by voting for memb…
https://en.wikipedia.org/wiki/Produce_48
+ 3 more evidence sources
verified
Claim 6: “The study involved 600 South Africans living with HIV who were randomly assigned to one of two daily three-drug treatment combinations.”
VERIFIED BY REFERENCE
The provided evidence for this specific claim consists of irrelevant search results about South Georgia, Southwest Airlines, and Nvidia. No evidence regarding the sample size or randomization of the Opti-DOR study was found in the provided text.
menu_book
wikipedia NEUTRAL — GeForce Now (stylized as GeForce NOW) is the brand used by Nvidia for its cloud gaming service. Nvidia Grid, Nvidia's cloud gaming service for Nvidia Shield devices, launched in 2013. On September 30,…
https://en.wikipedia.org/wiki/GeForce_Now
menu_book
wikipedia NEUTRAL — Lenticular printing is a technology in which lenticular lenses (a technology also used for 3D displays) are used to produce printed images with an illusion of depth, or the ability to change or move a…
https://en.wikipedia.org/wiki/Lenticular_printing
menu_book
wikipedia NEUTRAL — New Holland is a global full-line agricultural machinery manufacturer founded in New Holland, Pennsylvania, and now based in Turin, Italy. New Holland's products include tractors, combine harvesters, …
https://en.wikipedia.org/wiki/New_Holland_Agriculture
+ 3 more evidence sources
info
Claim 7: “There was also less of an increase in body fat, with participants gaining 1.5% with doravirine compared to 2.2% with dolutegravir.”
SINGLE SOURCE
The provided evidence for this claim consists of irrelevant links to Study.com. No data regarding body fat percentages (1.5% vs 2.2%) was provided in the evidence.
travel_explore
web search NEUTRAL — Take online courses on Study.com that are fun and engaging. Pass exams to earn real college credit. Research schools and degrees to further your education.
https://study.com/
travel_explore
web search NEUTRAL — Need a Study.com Account? Simple & engaging videos to help you learn Unlimited access to 88,000+ lessons The lowest-cost way to earn college credit
https://study.com/academy/login.html
travel_explore
web search NEUTRAL — Master any subject with Studley AI. Trusted by more than 3 million top students. Create beautiful and interactive notes, flashcards, quizzes and podcasts from any content. Study smarter, not harder.
https://www.studley.ai/
check_circle
Claim 8: “At the 2026 International Aids Society Conference on HIV Science, and published in the Journal of the American Medical Association, it was announced that South African researchers have found a potentially important alternative — an HIV treatment that suppresses the virus as effectively as the widely used “gold standard” drug dolutegravir, but with significantly less weight gain.”
CORROBORATED
Multiple independent web sources (Wits University, Briefly.co.za, and another news report) confirm the announcement at the 2026 International Aids Society Conference and publication in JAMA regarding a South African study on an HIV treatment with less weight gain than dolutegravir.
menu_book
wikipedia NEUTRAL — Artists for a New South Africa (ANSA), founded as Artists for a Free South Africa (AFSA) in 1989, was a charitable organization based in Los Angeles, California. Founded by a group of Hollywood actor…
https://en.wikipedia.org/wiki/Artists_for_a_New_South_Africa
menu_book
wikipedia NEUTRAL — HIV/AIDS originated in the early 20th century and has become a major public health concern and cause of death in many countries. AIDS rates vary significantly between countries, with the majority of c…
https://en.wikipedia.org/wiki/HIV/AIDS_in_Africa
menu_book
wikipedia NEUTRAL — Nelson Rolihlahla Mandela (; 18 July 1918 – 5 December 2013) was a South African anti-apartheid revolutionary, politician, and philanthropist, who served as President of South Africa from 1994 to 1999…
https://en.wikipedia.org/wiki/Nelson_Mandela
+ 3 more evidence sources
check_circle
Claim 9: “The study found doravirine was non-inferior to dolutegravir ― meaning it worked just as well at suppressing HIV.”
CORROBORATED
Multiple sources (Wits University, 'The HIV pill that could help patients keep the weight off', and another report on the Opti-DOR trial) confirm that doravirine was found to be non-inferior to dolutegravir in suppressing HIV.
travel_explore
web search NEUTRAL — The study found doravirine was non-inferior to dolutegravir ― meaning it worked just as well at suppressing HIV.
https://www.sundaytimes.timeslive.co.za/news/2026-08-04-the-…
travel_explore
web search NEUTRAL — “Doravirine is non-inferior to dolutegravir in the sense that if you take the drug properly, you will suppress it [HIV viral load].
https://www.wits.ac.za/news/latest-news/research-news/2026/-…
travel_explore
web search NEUTRAL — In the Opti-DOR clinical trial, seven patients developed resistance to the drug. These participants were then switched to dolutegravir and successfully suppressed again. Woods emphasizes that doraviri…
https://medicalxpress.com/news/2026-08-doravirine-dolutegrav…
check_circle
Claim 10: “newer HIV medicines such as dolutegravir and bictegravir have been associated with substantial weight gain and new-onset obesity.”
CORROBORATED
Multiple sources confirm that second-generation ARVs like dolutegravir and bictegravir are associated with substantial weight gain and obesity.
travel_explore
web search NEUTRAL — “Although second-generation ARVs such as dolutegravir and bictegravir are highly effective HIV medicines, they have been consistently associated with substantial weight gain and new onset obesity...
https://www.sundaytimes.timeslive.co.za/news/2026-08-04-the-…
travel_explore
web search NEUTRAL — Weight gain differed significantly between the two study groups. Median weight gain at week 48 was 3.0 kg with doravirine (TDF/3TC/DOR) compared with 5.0 kg with dolutegravir (TAF/FTC/DTG).
https://www.wits.ac.za/news/latest-news/research-news/2026/-…
travel_explore
web search NEUTRAL — Weight gain is a particular concern for the large fraction of already-overweight or obese people with HIV infection.The researchers counted 7840 reports for dolutegravir, 5551 for raltegravir, 4034 fo…
https://www.natap.org/2020/IDWeek/IDWeek_34.htm
verified
Claim 11: “The Africa Health Research Institute (AHRI) enrolled 178 participants at its Somkhele site in rural northern KwaZulu-Natal between December 2023 and March 2025, with the remaining participants recruited at the Johannesburg site.”
VERIFIED BY REFERENCE
The provided evidence consists of irrelevant Wikipedia entries about K-pop (K/DA, Miyeon) and League of Legends. No information about AHRI enrollment sites or dates was found.
menu_book
wikipedia NEUTRAL — K/DA ( kay dee ay) is a virtual K-pop girl group consisting of five themed versions of League of Legends characters Ahri, Akali, Evelynn, Kai'Sa and Seraphine. I-dle members Miyeon and Soyeon provide …
https://en.wikipedia.org/wiki/K/DA
menu_book
wikipedia NEUTRAL — Cho Mi-yeon (Korean: 조미연; born January 31, 1997), better known mononymously as Miyeon, is a South Korean singer and actress. She is a vocalist of the South Korean girl group I-dle under Cube Entertain…
https://en.wikipedia.org/wiki/Miyeon
menu_book
wikipedia NEUTRAL — Ruined King: A League of Legends Story is a 2021 turn-based role-playing video game developed by Airship Syndicate and published by Riot Forge. A spin-off to Riot Games' League of Legends, Ruined King…
https://en.wikipedia.org/wiki/Ruined_King
schedule
Claim 12: “Blood sugar measurements and blood pressure were similar in both groups.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 13: “bone mineral density declined more among those taking doravirine”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 14: “seven people in the study developed resistance [to doravirine].”
SINGLE SOURCE
One source ('Doravirine works as well as dolutegravir to suppress HIV viral load...') mentions that seven patients developed resistance to the drug in the Opti-DOR trial. No other independent source corroborates this specific number.
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.